In a UK-wide survey, 28% of neonatal units reported using systemic or topical/oral antifungal prophylaxis for very-low-birth-weight infants. Systemic prophylaxis is targeted to extremely preterm infants with additional risk factors for invasive fungal infection. Currently, there appears to be sufficient equipoise to undertake further randomised controlled trials of these interventions.
- antifungal prophylaxis
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.